Scott N. Boyle

Insider Reports History

Entity
Individual
Location
C4 Therapeutics, Inc., 490 Arsenal Way, Suite 200, Watertown, MA
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott N. Boyle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief Business Officer Common Stock 56.6K $342K $6.04 Nov 7, 2024 Direct
C4 Therapeutics, Inc. Chief Business Officer Performance Restricted Stock Units 10.5K $63.4K $6.04 Nov 7, 2024 Direct
C4 Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 115K Mar 7, 2024 Direct

Insider Reports Filed by Scott N. Boyle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CCCC C4 Therapeutics, Inc. Nov 7, 2024 3 -$6.66K 4 Nov 12, 2024 Chief Business Officer
CCCC C4 Therapeutics, Inc. Sep 16, 2024 3 -$4.2K 4 Sep 17, 2024 Chief Business Officer
CCCC C4 Therapeutics, Inc. Mar 7, 2024 2 $0 4 Mar 8, 2024 Chief Business Officer
CCCC C4 Therapeutics, Inc. Feb 13, 2024 3 -$11.3K 4 Feb 15, 2024 Chief Business Officer
CCCC C4 Therapeutics, Inc. Sep 18, 2023 1 $0 4 Sep 19, 2023 Chief Business Officer
CCCC C4 Therapeutics, Inc. Aug 30, 2023 3 -$1.94K 4 Aug 31, 2023 Chief Business Officer
CCCC C4 Therapeutics, Inc. Feb 13, 2023 2 $0 4 Feb 15, 2023 Chief Business Officer
CCCC C4 Therapeutics, Inc. Jan 30, 2023 3 -$9.51K 4 Feb 1, 2023 Chief Business Officer
CCCC C4 Therapeutics, Inc. May 26, 2022 1 -$7.73K 4/A Jun 14, 2022 Chief Business Officer
CCCC C4 Therapeutics, Inc. May 25, 2022 2 $0 4 May 27, 2022 Chief Business Officer
CCCC C4 Therapeutics, Inc. Mar 16, 2022 0 $0 3 Mar 17, 2022 Chief Business Officer